Published in Vaccine Weekly, March 2nd, 1998
Now, in a study in The Lancet, a research team from Sweden has reported that this vaccine was not effective for patients in this age group (Lancet, February 7, 1998;350:399-403).
Dr. Ake Ortqvist and colleagues from various centers in Sweden enrolled into their study 691 patients aged 50-85 years who had been in-patients for community-acquired pneumonia. Apart from the bout of pneumonia they were treated for, the patients were not otherwise immunologically...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.